Title of Invention

SULPHUR-CONTAINING METATHESIS CATALYSTS

Abstract The present invention relates to novel transition metal complexes of the formula (I) to a process for preparing these transition metal complexes and to the use of the transition metal complexes as catalysts in metathesis reactions.
Full Text

Sulphur-containing metathesis catalysts
The present invention relates to novel transition metal
complexes of the formula (I)

to a process for preparing these transition metal complexes
and to the use of the transition metal complexes as catalysts
in metathesis reactions .
Metathesis is understood to mean a chemical reaction in which
formal substituents on double or triple bonds are exchanged.
The metathesis reactions include the oligomerization and
polymerization of acyclic dienes (ADMET) or polymerization of
cyclic olefins (ROMP), and also the synthesis of cyclic
compounds of different sizes by ring-closing metathesis (RCM).
In addition, crossed metatheses of different alkenes (CM) and
metathesis of alkenes with alkynes (ene-yne metathesis) are
known. Numerous fundamental studies have contributed
significantly to the understanding of this transition metal-
catalysed reaction (for an overview see: Handbook of
Metathesis, Ed. R.H. Grubbs, WILEY-VCH, Weinheim, 2003).
For olefin metathesis, a multitude of catalyst systems is
available. Especially studies by Schrock introduced alkylidene
complexes of molybdenum and of tungsten as the first well-
defined catalysts (J.S. Murdzek, R.R. Schrock,
Organometallics, 1987, 6, 1373-1374). However, a disadvantage
was found to be the high sensitivity of these complexes. In
recent times, ruthenium-alkylidene complexes with phosphine
ligands have become established (P. Schwab et al. Angew. Chem.
Int. Ed. Engl. 1995, 34, 2039-2041; P. A. van der Schaaf et
al. J. Organometallic Chem. 2000, 606, 65-74). These complexes
possess a high tolerance toward polar functional groups and
are air- and water-stable. The introduction of N-heterocyclic

carbenes (NHC) as ligands allowed not only the activity of
these systems to be enhanced further, but also, owing to the
significant variability of the ligand sphere, made available
new kinds of control means for the reactions (DE 19815275 and
T. Weskamp, W.C. Schattenmann, M. Spiegler, W.A. Herrmann
Angew. Chem. 1998, 110, 263-2633). A further significant
increase in the catalytic activity is achieved by
supplementation with a more coordinatively labile ligand
(DE 19902439 and T. Weskamp, F. J. Kohl, W. Hieringer, D.
Gleich, W. A. Herrmann Angew. Chem., 1999, 111, 2573-2576).
Representative examples are the complexes A and B.

Gessler et al. (Tetrahedron Lett. 2000, 41, 9973-9976) and
Garber et al. (J. Am. Chem. Soc. 2000, 122, 8168-8179)
describe ruthenium complexes which, as well as an N-hetero-
cyclic carbene ligand, have an isopropoxybenzylidene ligand.
These so-called "green" catalysts have a higher stability and
can optionally be recycled.
The patent WO 9900397 describes catalysts C and D, which are
particularly suitable for ROMP. The further examples of such
highly active metathesis catalysts (E and F) are described in
the application WO 2005094345.


Some examples of metathesis catalysts with sulphur-containing
units in the side chain have been described in the literature
(complex H in P. A. van der Schaaf et al. J. Organometallic
Chem. 2000, 606, 65-74, complex Jl in Patent CN 2005100803792
and complex J2 in M. Bieniek et al. J. Organomet. Chem. 2006,
691, 5289).

Nevertheless, there was still a need for novel catalyst
systems for olefin metathesis which are stable and
additionally exhibit a high, possibly controllable activity
and can be utilized as alternative catalysts to the existing
catalysts. In particular, the catalysts, viewed as a whole,
should be superior to the prior art catalysts viewed from the
economic and/or ecological standpoint.
Surprisingly, compounds of the formula (I) have now been found


in which
M is Ru or, Os, preferably Ru,
L and L' are the same or different and are each independently
an uncharged electron donor,
X1 and X2 are the same or different and are each an anionic
ligand,
R is hydrogen, a cyclic, straight-chain or branched-chain
alkyl radical or optionally substituted aryl radical,
Z is a sulphur-containing unit which coordinates directly to
the metal, and
A is a bridge which bonds the Z unit covalently to the carbene
carbon, and n is 0 or 1, preferably 0.
Olefin metathesis with the inventive complexes is notable for
low activity at room temperature and an especially rapid rise
in activity with increasing temperature. As a result, the
inventive compounds can be used as thermally switchable
catalysts. Furthermore, the inventive complexes are air-stable
compounds and have remarkable thermal stability with an
activity which is not significantly lower than that of the
prior art catalysts.
Variation of the uncharged electron donor ligands L and L'
allows the activity and selectivity of the complexes also to
be controlled as appropriate. The inventive complexes
preferably have saturated or unsaturated NHC (N-heterocyclic
carbenes) as ligands for L. As well as their variety for the
modelling of the ligand sphere, these are notable especially
for provision of high catalyst activities. Such ligands are
mentioned by way of example in the following literature:
DE 19815275 and T. Weskamp, W.C. Schattenmann, M. Spiegler,
W.A. Herrmann Angew. Chem. 1998, 110, 263-2633; DE 19902439
and T. Weskamp, F. J. Kohl, W. Hieringer, D. Gleich, W.
A. Herrmann Angew. Chem., 1999, 111, 2573-2576; EP 1180108. L'

may be L or assume the structures listed in WO 9951344 as
uncharged electron donor ligands.
In the inventive complexes, the abovementioned sulphur-
containing Z unit is preferably radicals from the group of:
thiol, thioether, thioacetals, disulphides, dithiocarboxylic
acids, thioesters, thioketones, thioaldehydes, thiocarbamates,
thiourethanes, phosphine sulphides, thiophosphates,
thiophosphonates, sulphonates, sulphones, sulphonamides or
sulphur-containing heterocycles, while it must be ensured that
the compound Z-M, preferably Z-Ru, is formed via the sulphur
atom or an oxygen atom disposed on the sulphur. This will
preferably be the case when the coordinating ring closure
between the sulphur or the oxygen atom and the metal atom
forms a 5-, 6- or 7-membered ring.
For the bridging molecular moiety A, the person skilled in the
art can in principle use a radical which appears to be useful
for the present purpose: preference is given to a carbon
skeleton which consists of 2 to 4 carbon atoms, particular
preference to a C2 bridge, where the two carbon atoms may have
sp2 hybridization and the radical advantageously forms part of
a 3-, 4-, 5-, 6-, 7- or 8-membered ring system. The ring
systems just addressed may optionally have one or more
heteroatoms. Useful such heteroatoms are especially oxygen,
sulphur or nitrogen atoms. They may be unsaturated further
over and above the sp2 hybridization described and optionally
be of aromatic nature. They may be mono- or polysubstituted by
further radicals, especially those selected from the group
consisting of (C1-C8) -alkyl, (C1-C8)-alkoxy, (C6-C18) -aryloxy,
HO-(C1-C8)-alkyl, (C2-C8)-alkoxyalkyl, (C6-C18)-aryl,
(C7-C19)-aralkyl, (C3-C18) -heteroaryl, (C4-C19)-heteroaralkyl,
(C1-C8) -alkyl- (C6-C18) -aryl, (C1-C8) -alkyl- (C3-C18) -heteroaryl,
(C3-C8) -cycloalkyl, (C1-C8) -alkyl- (C3-C8) -cycloalkyl,
(C3-C8) -cycloalkyl- (C1-C8) -alkyl.
In addition, the ring systems may also have one or more
substituents, especially those selected from the group
consisting of halogen, hydroxyl, carboxylic acids, esters,
silyl ethers, thioethers, thioacetals, imines, silyl enol

ethers, ammonium salts, amides, nitriles, perfluoroalkyl
groups, ketones, aldehydes, carbamates, carbonates, urethanes,
sulphonates, sulphones, sulphonamides, nitro groups,
organosilane units, phosphonate and phosphate groups, and
phosphonium salts.
In the inventive complexes, the anionic ligands X1 and X2 are
preferably inorganic or organic anions from the group of
halides, especially F-, Cl-, Br-, pseudohalides, hydroxides,
alkoxides or amides (RO-, R2N-) , phenols, thiols, thiophenols,
carboxylates, carbonates, sulphonates, sulphates, phosphates
and phosphonates, allyl and cyclopentadienyl, the
pseudohalides being understood to mean preferably cyanide,
thiocyanate, cyanate, isocyanate and isothiocyanate, where the
R radicals satisfy the definition given below.
Very particular preference is given to complexes of the
general formula (II) and (III).

In these complexes, Z is -S-, -S(O)- and S(O)2-,
X1 and X2 assume the definitions given above,
Y, R, R' and R1 to R4 are each independently selectable
radicals from the group of hydrogen, (C1-C8)-alkyl,
(C1-C8)-alkoxy, (C6-C18)-aryloxy, HO- (C1-C8) -alkyl,
(C2-C8)-alkoxyalkyl, (C6-C18)-aryl, (C7-C19)-aralkyl,
(C3-C18) -heteroaryl, (C4-C19) -heteroaralkyl,
(C1-C8) -alkyl- (C6-C18) -aryl, (C1-C8) -alkyl- (C3-C18) -heteroaryl,
(C3-C8) -cycloalkyl, (C1-CB) -alkyl- (C3-C8) -cycloalkyl,
(C3-C8)-cycloalkyl-(C1-C8)-alkyl. Moreover, the R' and R1 to R4

radicals may each independently be: (cyclo)alkylthio,
(hetero)arylthio, alkyl/arylsulphonyl, alkyl/arylsulphynyl, in
each case optionally substituted by (C1-C8)-alkyl,
(C1-C8)-alkoxy, (C6-C1B) -aryloxy, HO-(C1-C8)-alkyl,
(C2-C8)-alkoxyalkyl, (C6-C18) -aryl, perf luoroalkyl, halogen,
(C1-C8)-acyloxy, (C1-C8)-acyl (C1-C8)-alkoxycarbonyl,
(C1-C8)-alkylsulphonyl or (C1-C8)-alkylsulphinyl,
(C6-C18)-arylsulphonyl or (C6-C18)-arylsulphinyl.
R1 to R4 may likewise be a nitro group, sulphate, amine,
ammonium salt, phosphate and phosphonium salt.
The R' radicals may be present with one or more of the R1 to R4
radicals bonded to one another in cyclic compounds. The R1
radical may also be joined to the Y radical to form a
(hetero)cyclic compound.
The inventive compounds, especially those of the formula (I)
and (II), are preferably prepared by exchange reaction of the
phosphine ligand in compounds of the formula (IV) for ligands
of the formula (V)

in which the radicals each assume the definitions specified
above and PR3 is a phosphine ligand, preferably tricyclohexyl-
phosphine.
The inventive compounds, especially those of the formula (I)
and (II) are prepared from compounds of the formula (VI)
preferably in a solvent, more preferably in toluene, benzene,
tetrahydrofuran or dichloromethane, most preferably in
dichloromethane. The reaction preferably takes place in the
presence of compounds which are capable of scavenging
phosphines, more preferably in the presence of CUCl2 and CuCl,
most preferably in the presence of CuCl. Preference is given
to working in the presence of equimolar amounts or of an

excess of phosphine scavenger, based on compounds of the
formula (IV). When the phosphine scavenger used is CuCl,
particular preference is given to using 1 to 1.5 equivalents.
Preference is given to using 0.9 to 3 equivalents of the
compounds of the formula (V), based on compounds of the
formula (IV), particular preference to using 1 to 2
equivalents. The reaction is effected preferably at
temperatures of 20 to 80°C, more preferably at temperatures of
30 to 50°C. The reaction is preferably carried out under inert
gas, for example nitrogen or argon.
The inventive compounds (I), especially those of the formula
(II) and (III), can be used as catalysts in metathesis
"reactions'."'they can be used, for example, in ring-closing
metatheses. They are more preferably used in ROMP and ADMET
polymerization reactions.
Alkyl radicals are considered especially to be (C1-C8)-alkyl radicals, for example methyl, ethyl, n-propyl, isopropyl,
n-butyl, isobutyl, sec-butyl, tert-butyl, pentyl, hexyl,
heptyl or octyl including all of their bonding isomers.
The (C1-C8)-alkoxy radical corresponds to the (C1-C8) -alkyl
radical with the proviso that it is bonded to the molecule via
an oxygen atom.
(C2-C8)-Alkoxyalkyl means radicals in which the alky chain is
interrupted by at least one oxygen function, but two oxygen
atoms cannot be bonded to one another. The number of carbon
atoms indicates the total number of carbon atoms present in
the radical.
A (C3-C5)-alkylene bridge is a carbon chain with three to five
carbon atoms, this chain being bonded to the molecule in
question via two different carbon atoms.
The radicals described in the preceding paragraphs may be
mono- or polysubstituted by halogens and/or radicals
containing nitrogen, oxygen, phosphorus, sulphur, silicon
atoms. These are especially alkyl radicals of the type
mentioned above which have one or more of these heteroatoms in
their chain or which are bonded to the molecule via one of
these heteroatoms.

(C3-C8)-Cycloalkyl is understood to mean cyclopropyl,
cyclobutyl, cyclopentyl, cyclohexyl or cycloheptyl radicals,
etc. They may be substituted by one or more halogens and/or
radicals containing nitrogen, oxygen, phosphorus, sulphur,
silicon atoms and/or have nitrogen, oxygen, phosphorus,
sulphur atoms in the ring, for example 1-, 2-, 3-, 4-
piperidyl, 1-, 2-, 3-pyrrolidinyl, 2-, 3-tetrahydrofuryl, 2-,
3-, 4-morpholinyl.
A (C3-C8)-cycloalkyl-(C1-C8)-alkyl radical denotes a cycloalkyl
radical as represented above, which is bonded to the molecule
via an alkyl radical as specified above.
In the context of the invention, (C1-C8)-acyloxy means an alkyl
radical as defined above with max. 8 carbon atoms, which is
bonded to the molecule via a COO function.
In the context of the invention, (C1-C8)-acyl means an alkyl
radical as defined above with max. 8 carbon atoms, which is
bonded to the molecule via a CO function.
An aryl radical is understood to mean especially a (C6-C18)-
aryl radical which is an aromatic radical having 6 to 18
carbon atoms. In particular, this includes compounds such as
phenyl, naphthyl, anthryl, phenanthryl, biphenyl radicals or
systems of the type described above fused to the molecule in
question, for example indenyl systems, which may optionally be
substituted by halogen, (C1-C8) -alkyl, (C1-C8)-alkoxy, NH2,
NH(C1-C8) -alkyl, N ( (C1-C8) -alkyl) 2, OH, CF3, NH (C1-C8)-acyl,
N( (C1-C8)-acyl)2 , (C1-C8)-acyl, (C1-C8) -acyloxy.
A (C7-C19)-aralkyl radical is a (C6-C18)-aryl radical bonded to
the molecule via a (C1-C8) -alkyl radical.
In the context of the invention, a (C3-C18)-heteroaryl radical
denotes a five-, six- or seven-membered aromatic ring system
which is composed of 3 to 18 carbon atoms and has heteroatoms,
for example nitrogen, oxygen or sulphur, in the ring. Such

heteroaromatics are considered especially to be radicals such
as 1-, 2-, 3-furyl, 1-, 2-, 3-pyrrolyl, 1-, 2-, 3-thienyl, 2-,
3-, 4-pyridyl, 2-, 3-, 4-, 5-, 6-, 7-indolyl, 3-, 4-,
5-pyrazolyl, 2-, 4-, 5-imidazolyl, acridinyl, quinolinyl,
phenanthridinyl, 2-, 4-, 5-, 6-pyrimidinyl. This radical may
be substituted by the same radicals as the aryl radical
specified above.
A (C4-C19)-heteroaralkyl is understood to mean a heteroaromatic
system corresponding to the (C7-C19)-aralkyl radical.
Useful halogens (Hal) include fluorine, chlorine, bromine and
iodine.

Examples
1. Synthesis of 2-(isopropylthio)benzoic acid

To a suspension of thiosalicylic acid (16.7 g; 109 mmol;
Fluka) and isopropyl bromide (20.0 g; 163 mmol) in ethanol
(125 ml) were added slowly, with vigorous stirring, KOH
pellets (17.3 g; 433 mmol). After stirring for 6 h, the
reaction mixture was poured into water-ice mixture (1200 ml)
and acidified with concentrated hydrochloric acid (approx.
50 ml). The precipitated product was filtered off, washed with
50% aqueous ethanol (2 x 100 ml) and dried under reduced
pressure. Yield 6.4 g (30%).
IR (film): v 3084, 3058, 2962, 2924, 2865, 1828, 1625, 1588,
1463, 1365, 1243, 1197, 1155, 1049, 991, 912, 769, 746 cm-1; 1H
NMR (200 MHz, DMSO-d6) δ 1.74-1.82 (d, 6H, J = 2.2 Hz), 4.02-
4.12 (septet, 1H, J = 6.6 Hz), 7.70 (m, 1H), 7.66-7.72 (m,
1H), 7.95-8.00 (m, 2H), 8.36-8.42 (m, 1H) ; 13C NMR (50 MHz,
DMSO-d6) δ 22.4, 35.3, 124.6, 128.3, 131.1, 132.1, 140.3,
167.2, 205.6; MS (EI) m/z (rel intensity) 196 (21, [M]+'),
154(13), 137(11), 136(100), 108(21), 69(8), 43(13), 41(13),
39(12) ; HRMS (EI): calcd for [M]+- (C7H12O2S) : 196. 05580;
found 196.05604.
2. Synthesis of 2-(isopropylthio)benzaldehyde

To a solution of 2-(isopropylthio)benzoic acid (0.98 g,
5 mmol) in THF (10 ml) was added dropwise borane-dimethyl
sulphide complex (0.8 ml, 8 mmol) at 3°C under argon with

vigorous stirring. After continuing to stir in an ice bath for
30 min, the reaction was left to stand at RT for a further
24 h. Methanol (1.5 ml) was added cautiously and the reaction
solution was concentrated under reduced pressure. The residue
was taken up in diethyl ether (50 ml), and washed with
saturated K2CO3 solution and NaCl solution. Aqueous solutions
were additionally extracted with ether, the combined organic
phases were dried over MgSO4 and filtered, and the solvent was
removed under reduced pressure. The residue was taken up in
dichloromethane (30 ml), admixed cautiously with PCC (1.20 g,
5.6 mmol) and stirred at room temperature for 36 h. After
solvent removal, the residue was purified by column
chromatography on silica gel (10:1 hexane:ethyl acetate).
Yield 0.69 g (76%).
IR (film): v 3686, 3601, 3362, 3063, 2968, 2929, 2867, 2744,
1950, 1692, 1648, 1587, 1559, 1460, 1442, 1383, 1368, 1287,
1242, 1195, 1156, 1128, 1073, 1062, 1052, 1039, 931, 879, 845,
825, 777, 679, 660, 635, 509 cm-1; 1H NMR (200 MHz, CDC13) δ
1.30-1.40 (d, 6H, J = 6.6 Hz), 3.38-3.48 (septet, 1H, J = 6.8
Hz), 7.25-7.60 (m, 3H), 7.84-7.92 (m, 1H), 10.54 (d, 1H, J=
0.63 Hz); 13C NMR (50 MHz, CDC13) δ 22.9, 38.8, 126.7, 130.1,
132.4, 133.8, 135.8, 140.3, 191.9; MS (EI) m/z (rel intensity)
180(66, [M]+.), 165(18), 138(49), 137(100), 110(35), 109(41),
104(57), 69(11), 66(11), 65(26), 43(25), 41(19), 39(17); HRMS
(EI): calcd for [M]+. (C10H12OS): 180. 07122; found 180.07148.
3. Synthesis of 2-isopropylsulphinylbenzaldehyde

A solution of 2-(isopropylthio)benzaldehyde (0.33 g,
1.83 mmol) in dichloromethane (10 ml) was admixed with aqueous
KHCO3 solution (1.18 g in 10 ml of H2O). With vigorous
stirring, a solution of bromine (0.310 g, 1.93 mmol) in
dichloromethane (1.5 ml) was added dropwise. After continuing

to stir for 20 min, a spatula-tip of Na2SO3 was added, and the
organic phase was removed, washed with saturated NaCl
solution, dried over MgSO4 and filtered, and the solvent was
removed under reduced pressure. The residue was purified by
column chromatography on silica gel (3:1 to 1:1 hexane:ethyl
acetate). The product precipitated out as a yellowish oil.
Yield 0.304 g (85%).
IR (film): v 3447, 2963, 2917, 2864, 2738, 1702, 1628, 1607,
1482, 1439, 1380, 1264, 1227, 1183, 1158, 1121, 1105, 1037,
992, 950, 932, 852, 803, 751, 697, 635, 593, 578, 535, 506,
446, 418 cm-1; 1H NMR (200 MHz, CDC13) δ 0.86-0.94 (d, 3H, J =
6.8 Hz), 1.50-1.56 (d, 3H, J = 7.1 Hz), 2.90-3.10 (septet,
1H, J = 6.8 Hz), 7.60-8.00 (m, 1H), 8.16-8.22 (m, 1H), 10.01-
10.06 (d, 1H J = 0.63 Hz); 13C NMR (50 MHz, CDC13) δ 21.7,
38.2, 124.4, 130.5, 133.9, 135.2, 144.9, 198.5; MS (EI) m/z
(rel intensity) 180(66, [M]+.), 165(18), 138(49), 137(100),
110(35), 109(41), 104(57), 69(11), 66(11), 65(26), 43(25),
41(19), 39(17); HRMS (EI): calcd for [M]+. (C7H10O2S): 178.
08162; found 178.08148.
4. Wittig olefination
To a suspension of methyltriphenylphosphonium bromide
(0.690 g, 1.93 mmol, Aldrich) in 8 ml of THF was added
dropwise n-BuLi (1.5 M, 1.4 ml, 2.07 mmol) at -78°C under an
argon atmosphere. The yellow reaction solution was warmed to
room temperature within 1 h. After cooling again to -78°C, a
solution of the appropriate aldehyde (1.39 mmol) in THF (5 ml)
was added, then the mixture was warmed slowly to room
temperature and stirred at this temperature for 1 h. After
adding a saturated NH4C1 solution, the aqueous phase was
extracted with ethyl acetate (4 x 20 ml). The combined organic
phases were dried over MgSO4 and the solvent was removed under
reduced pressure. The residue was purified by column
chromatography on silica gel (2:8 cyclohexane:ethyl acetate).

4a. 2-Isopropylthio-l-vinylbenzene

Yield 74%.
IR (film): v 3084, 3058, 2962, 2924, 2865, 1828, 1625, 1588,
1463, 1365, 1243, 1197, 1155, 1049, 991, 912, 769, 746 cm-1; 1H
NMR (500 MHz, CDC13) δ 1.26 (d, 6H, J = 6.7 Hz), 3.24-3.33
(septet, 1H, J = 6.7 Hz), 5.30 (dd, 1H, J = 1.2, 11 Hz), 5. 67
(dd, 1H, J= 1.2, 17.5 Hz), 7.18-7.27 (m, 2H), 7.35 (dd, 1H,
J = 11, 17.5 Hz), 7.42-7.47 (m, 1H), 7. 52-7. 57 (m, 1H);
13C NMR (125 MHz, CD3CCD3) δ 23.1, 38.8, 115.3, 125.9, 127.5,
127.9, 133.8, 133.9, 135.3, 140.2; MS (EI) m/z (rel intensity)
178 (9, [M]+-), 136(10), 135(100), 134(14), 91(18), 77(2),
65(1), 43(2); HRMS (EI): calcd for [M]+. (CuHi4S) : 178. 08162;
found 178.08148.
4b. 2-Isopropylsulphinyl-l-vinylbenzene

Yield 71%.
IR (film): v 3686, 3603, 3411, 2982, 2933, 2870, 2543, 2049,
1969, 1940, 1856, 1727, 1628, 1606, 1562, 1465, 1440, 1414,
1384, 1366, 1193, 1158, 1125, 1069, 1024, 990, 956, 926, 891,
875, 638, 582, 549, 506 cm-1; 1H NMR (400 MHz, CDC13) 6 1.06 (d,
3H, J = 7.0 Hz), 1.3 (d, 3H, J = 7.0 Hz), 2.83-2.93 (septet,
1H, J = 7.1 Hz), 5.41 (dd, 1H, J = 0.83, 11 Hz), 5. 77 (dd,
1H, J = 0.96, 17.3 Hz), 6.93-7.02 (q, 1H, J = 11 Hz), 7.44-
7.58 (m, 2H) , 7.86-7.89 (m, 1H, J = 11, 17.5 Hz); 13C NMR (100

MHz, CDCl3) δ 13.1, 17.1, 53.2, 117.8, 124.8, 125.7, 128.3,
130.7, 131.6, 135.9, 139.8; MS (EI) m/z (rel intensity) 194
(4, [M]+.), 152(13), 137(10), 136(11), 135(100), 134(11),
91(21), 77(11), 51(7), 45(8), 43(11), 41(9), 39(8); HRMS (EI):
calcd for [M]+- (C11H14OS) : 194. 07654; found 194.07703.
5. Ru complex synthesis
To a suspension of copper(I) chloride (13 mg, 0.12 mmol) and
tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)-4,5-
dihydroimidazol-2-ylidene][benzylidene]ruthenium(IV)
dichloride (102 mg; 0.12 mmol) in 2 ml of dichloromethane was
added a solution of the appropriate styrene derivative
(0.132 mmol) dissolved in 3 ml of dichloromethane. After
stirring at 40°C for 20 min, the reaction solution was
concentrated under reduced pressure. The residue was taken up
in 20 ml of ethyl acetate and filtered through a Pasteur
pipette with silica gel. The filtrate was concentrated again
under reduced pressure and the residue was washed with a very
small amount of ethyl acetate and cold pentane.
5a. Complex SR1

Green microcrystalline solid, yield 86%.
IR (film): v 2952, 2908, 2862, 1606, 1479, 1420, 1382, 1262,
1154, 1055, 1033, 863, 843, 798, 742 cm-1; 1H NMR (500 MHz,
CDCl3) δ 0.99 (d, 6H, J = 6.6 Hz), 2.37 (s, 6H), 2.48 (s, 12H),
3. 18 (septet, 1H, J = 6.6 Hz), 4.14 (s, 4H), 6.73 (d, 1H, J =
7.5 Hz), 7.03 (s, 4H), 7.11-7.20 (m, 1H); 7.40-7.52 (m, 2H),
17.33 (s, 1H) ; 13C NMR (125 MHz, CD3COCD3) 5 19.5, 21.0, 51.7,
121.8, 123.3, 129.3, 129.4, 133.6, 136.4, 138.1, 138.6, 140.0,
140.3, 156.2, 162.0, 210.0, 285.7;

MS (EI) m/z (rel intensity) 642 (8, [M]+-), 530(10), 528(18),
527(14), 526(13), 525(10), 305(40), 304(100), 303(91),
289(19), 287(10), 166(25), 163(12), 159(12), 158(22), 149(19),
146(12), 145(14), 144(13), 135(14), 124(32), 91(45), 77(15),
71(11), 57(14), 55(12), 45(10), 44(46), 43(33), 42(12),
41(35), 40(31), 39(20), 38(15), 36(46); HRMS (EI): calcd for
[M]+- (C31 H38N235Cl2 S 102Ru) : 642. 11762; found 642.11634.
Fig. 1: Crystal structure of complex SRI.
5b. Complex SOR1

Light green microcrystalline solid, yield 72%:
IR (film): v 3447, 2963, 2917, 2738, 1702, 1628, 1607, 1482,
1439, 1380, 1264, 1227, 1183, 1158, 1121, 1105, 1037, 992,
950, 932, 852, 803, 751, 697, 635, 593, 578, 535, 506, 446,
418 cm-1; 1H NMR (500 MHz, CDC13) δ 1.05 (q, 6H, J = 6.7 Hz),
2.29 (m, 3H), 2.35-2.45 (m, 12H), 2.55 (s, 3H), 3.61 (septet,
1H, J = 6.7 Hz), 4.15 (s, 4H), 6.74 (d, 1H, J = 7.6 Hz), 6.95-
7.05 (m, 4H), 7.34 (m, 1H), 7. 65 (m, 1H) 7.72-7.78 (m, 1H),
16.81 s, 1H) ; 13C NMR (125 MHz, CDC13) δ 21.0, 51.7, 121.0,
127.5, 128.9, 129.4, 129.6, 129.7, 133.9, 135.4, 138.1, 138.5,
138.9, 139.0, 156.2, 207.2, 301.3; MS (ESI; m/z): 658 [M - Cl
+ CH3CN]+.
6. RCM of N,N-diallyl-p-toluenesulphonamide


6a. In the presence of complex SR1
A solution of N, N-diallyl-p-toluenesulphonamide (0.350 mmol,
84 mg) in 17.5 ml of toluene was admixed with 5 mol% of
catalyst (0.018 mmol) SR1 from Example 5a under argon, and
stirred at 80°C. A 200 µl aliquot of the reaction solution was
added to 500 µl of 2M ethyl vinyl ether solution in methylene
chloride and analysed by means of GC. After 24 h, 51%
conversion to the desired N-p-toluenesulphonyl-2,5-
dihydropyrrole was found.
6b. In the presence of complex SOR1
A solution of N,N-diallyl-p-toluenesulphonamide (0.350 mmol,
84 mg) in 17.5 ml of dichloromethane was admixed with 5 mol%
of catalyst (0.018 mmol) SOR1 from Example 5b under argon, and
stirred at room temperature. A 200 µl aliquot of the reaction
solution was added to 500 µl of 2M ethyl vinyl ether solution
in methylene chloride and analysed by means of GC. The
progress of the reaction is shown in Figure 2.
Figure 2: RCM of N,N-diallyl-p-toluenesulphonamide in the
presence of 5 mol% of complex SOR1 in methylene chloride at
room temperature.
7. RCM of diethyl 2-allyl-2-(2-methylallyl)malonate

A solution of diethyl 2-allyl-2-(2-methylallyl)malonate
(0.350 mmol) in 17.5 ml of toluene was admixed with 1 mol% of
catalyst (0.0035 mmol) SOR1 from Example 5b under argon, and
stirred at 80°C. 200 µl of the reaction solution were added to
500 µl of 2M ethyl vinyl ether solution in methylene chloride
and analysed by means of GC. After 1 h, 99% conversion to the
desired 4,4-bis(ethoxycarbonyl)-1-methylcyclopentene was
found.

8. Ene-yne metathesis of 3-allyloxy-3,3-diphenylpropyne

A solution of 3-allyloxy-3,3-diphenylpropyne (0.350 mmol) in
17.5 ml of toluene was admixed with 5 mol% of catalyst
(0.018 mmol) SR1 from Example 5a under argon, and stirred at
80°C. 200 µl of the reaction solution were added to 500 µl of
2M ethyl vinyl ether solution in methylene chloride and
analysed by means of GC. After 1 h, 99% conversion to the
desired 3-ethenyl-2,5-dihydro-2,2-diphenylfuran was found.

WE CLAIM:
1. Compounds of the formula (II) or (III)

in which Z is -S-, -S(O)- and S(O)2-,
X1 and X2 are the same or different and are each an anionic ligand,
Y, R, R' and R1 to R4 are each independently selectable radicals from the
group of hydrogen, (C1-C8)-alkyl, (C1-C8)-alkoxy, (C6-C18)-aryloxy, HO-(C1-
C8)-alkyl, (C2-C8)-alkoxyalkyl, (C6-C18)-aryl, (C7-C19)-aralkyl, (C3-C18)-heteroaryl,
(C4-C19)-heteroaralkyl, (C1-C8)-alkyl-(C6-C18)-aryl, (C1-C8)-alkyl-(C3-C18)-
heteroaryl, (C3-C8) cycloalkyl, (C1-C8)-alkyl-(C3-C8)-cycloalkyl, (C3-C8)-cycloalkyl-
(C1-C8)-alkyl, or
R' and R1 to R4 radicals may each independently be: (cyclo)alkylthio,
(hetero)arylthio, alkyl/arylsulphonyl, alkyl/arylsulphynyl, in each case
optionally substituted by (C1-C8)-alkyl, (C1-C8)-alkoxy, (C6-C18)-aryloxy, HO-
(C1-C8)-alkyl, (C2-C8)-alkoxyalkyl, (C6-C18)-aryl, perfluoroalkyl, halogen,
(C1-C8)-acyloxy, (C1-C8)-acyl
(C1-C8)-alkoxycarbonyl, (C1-C8)-alkylsulphonyl or (C1-C8)-alkylsulphinyl,
(C6-C18)-arylsulphonyl or (C6-C18)-arylsulphinyl, or

R1 to R4 are respectively selected from a nitro group, sulphate, amine,
ammonium salt, phosphate and phosphonium salt, or
R' radicals is present with one or more of the R1 to R4 radicals bonded to
one another in cyclic compounds, or
R1 radical may also be joined to the Y radical to form a (hetero)cyclic
compound.
2. Compounds as claimed in claim 1,
wherein
X1 and X2 are each inorganic or organic anions from the group of
halides, pseudohalides, hydroxides, alkoxides or amides, phenols, thiols,
thiophenols, carboxylates, carbonates, sulphonates, sulphates,
phosphates and phosphonates, allyl and cyclopentadienyl.
3. Compounds as claimed in claim 2, wherein the halides are F-, C1- or
Br.
4. Compounds as claimed in claim 2, wherein the pseudohalides are
selected from cyanide, thiocyanate, cyanate, isocyanate and
isothiocyanate.
5. Process for performing metathesis reactions wherein a compound as
claimed in claim 1 is employed.


Abstract:

The present invention relates to novel transition metal
complexes of the formula (I)

to a process for preparing these transition metal complexes
and to the use of the transition metal complexes as catalysts
in metathesis reactions.

Documents:

00687-kol-2008-abstract.pdf

00687-kol-2008-claims.pdf

00687-kol-2008-correspondence others.pdf

00687-kol-2008-description complete.pdf

00687-kol-2008-drawings.pdf

00687-kol-2008-form 1.pdf

00687-kol-2008-form 2.pdf

00687-kol-2008-form 3.pdf

00687-kol-2008-form 5.pdf

00687-kol-2008-gpa.pdf

00687-kol-2008-translated copy of priority document.pdf

687-KOL-2008-(06-03-2012)-AMANDED CLAIMS.pdf

687-KOL-2008-(06-03-2012)-CORRESPONDENCE.pdf

687-KOL-2008-(06-03-2012)-DESCRIPTION (COMPLETE).pdf

687-KOL-2008-(06-03-2012)-DRAWINGS.pdf

687-KOL-2008-(06-03-2012)-FORM-1.pdf

687-KOL-2008-(06-03-2012)-FORM-2.pdf

687-KOL-2008-(06-03-2012)-OTHERS.pdf

687-KOL-2008-(06-03-2012)-PETITION UNDER RULE 137.pdf

687-KOL-2008-(08-08-2012)-CORRESPONDENCE.pdf

687-KOL-2008-(23-09-2011)-CORRESPONDENCE.pdf

687-KOL-2008-(23-09-2011)-OTHERS.pdf

687-KOL-2008-(23-09-2011)-PCT SEARCH REPORT.pdf

687-KOL-2008-CORRESPONDENCE 1.3.pdf

687-KOL-2008-CORRESPONDENCE 1.5.pdf

687-KOL-2008-CORRESPONDENCE OTHERS 1.1.pdf

687-KOL-2008-CORRESPONDENCE OTHERS 1.2.pdf

687-kol-2008-correspondence-1.4.pdf

687-KOL-2008-EXAMINATION REPORT.pdf

687-KOL-2008-FORM 1 1.1.pdf

687-KOL-2008-FORM 18 1.1.pdf

687-kol-2008-form 18.pdf

687-KOL-2008-FORM 3 1.1.pdf

687-KOL-2008-FORM 3.pdf

687-KOL-2008-FORM 5.pdf

687-KOL-2008-GPA.pdf

687-KOL-2008-GRANTED-ABSTRACT.pdf

687-KOL-2008-GRANTED-CLAIMS.pdf

687-KOL-2008-GRANTED-DESCRIPTION (COMPLETE).pdf

687-KOL-2008-GRANTED-DRAWINGS.pdf

687-KOL-2008-GRANTED-FORM 1.pdf

687-KOL-2008-GRANTED-FORM 2.pdf

687-KOL-2008-GRANTED-SPECIFICATION.pdf

687-KOL-2008-OTHERS 1.1.pdf

687-KOL-2008-OTHERS.pdf

687-KOL-2008-PRIORITY DOCUMENT 1.1.pdf

687-KOL-2008-PRIORITY DOCUMENT.pdf

687-KOL-2008-REPLY TO EXAMINATION REPORT.pdf

687-KOL-2008-TRANSLATED COPY OF PRIORITY DOCUMENT.pdf


Patent Number 254281
Indian Patent Application Number 687/KOL/2008
PG Journal Number 42/2012
Publication Date 19-Oct-2012
Grant Date 16-Oct-2012
Date of Filing 08-Apr-2008
Name of Patentee EVONIK DEGUSSA GMBH
Applicant Address RELLINGHAUSER STRASSE 1-11, 45128 ESSEN
Inventors:
# Inventor's Name Inventor's Address
1 DR. RENAT KADYROV WALTER-HESSELBACHSTR. 190 60389 FRANKFURT
2 DR. KAROL GRELA UL. PELCZYNSKIEGO 22 B, M. 45 01-471 WARSAW
3 DR. MICHAL BARBASIEWICZ CARL-THIERSCH-STRASSE 5 91052 ERLANGEN
4 ANNAL SZADKOWSKA UL. PRZY AGORZE 7 M. 159 01-960 WARSZAWA
PCT International Classification Number C07F15/00; B01J31/22
PCT International Application Number N/A
PCT International Filing date
PCT Conventions:
# PCT Application Number Date of Convention Priority Country
1 10 2007 020694.3 2007-05-03 Germany